Akhila Reddy, Ebtesam Islam, Benjamin Batson, Madison Taylor
{"title":"非小细胞肺癌的胸膜浸润","authors":"Akhila Reddy, Ebtesam Islam, Benjamin Batson, Madison Taylor","doi":"10.12746/swrccc.v11i49.1207","DOIUrl":null,"url":null,"abstract":"Pleural invasion is a recognized adverse prognostic factor in non-small cell lung cancer. Here, we document a case of non-small cell lung cancer in a 66-year-old male presenting with direct invasion of the tumor through lung pleura into the mediastinum. Pleural invasion can proceed past the elastic layer of the visceral pleura, classified as PL1. Less commonly, invasion to the surface of the visceral pleura or parietal pleura can occur and is classified as PL2 and PL3 respectively. PL2 invasion is associated with increased mortality; patients have lower overall survival compared to those without visceral pleural invasion (HR=2.447, 95% CI 0.336,0.579) and those with only PL1 invasion (HR=1.287, 95% CI 1.114, 1.487). Treatment of non-small cell lung cancer with pleural invasion includes surgery, chemotherapy, radiation, and immunotherapy.","PeriodicalId":22976,"journal":{"name":"The Southwest Respiratory and Critical Care Chronicles","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Pleural invasion in non-small cell lung cancer\",\"authors\":\"Akhila Reddy, Ebtesam Islam, Benjamin Batson, Madison Taylor\",\"doi\":\"10.12746/swrccc.v11i49.1207\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Pleural invasion is a recognized adverse prognostic factor in non-small cell lung cancer. Here, we document a case of non-small cell lung cancer in a 66-year-old male presenting with direct invasion of the tumor through lung pleura into the mediastinum. Pleural invasion can proceed past the elastic layer of the visceral pleura, classified as PL1. Less commonly, invasion to the surface of the visceral pleura or parietal pleura can occur and is classified as PL2 and PL3 respectively. PL2 invasion is associated with increased mortality; patients have lower overall survival compared to those without visceral pleural invasion (HR=2.447, 95% CI 0.336,0.579) and those with only PL1 invasion (HR=1.287, 95% CI 1.114, 1.487). Treatment of non-small cell lung cancer with pleural invasion includes surgery, chemotherapy, radiation, and immunotherapy.\",\"PeriodicalId\":22976,\"journal\":{\"name\":\"The Southwest Respiratory and Critical Care Chronicles\",\"volume\":\"1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-10-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Southwest Respiratory and Critical Care Chronicles\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.12746/swrccc.v11i49.1207\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Southwest Respiratory and Critical Care Chronicles","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12746/swrccc.v11i49.1207","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
胸膜浸润是公认的非小细胞肺癌的不良预后因素。在此,我们报告一位66岁男性非小细胞肺癌病例,表现为肿瘤经肺胸膜直接侵入纵隔。胸膜侵犯可越过内脏胸膜的弹性层,分类为PL1。不太常见的是,内脏胸膜表面或胸膜壁层也会发生侵犯,分别被分类为PL2和PL3。PL2侵袭与死亡率增加有关;与没有内脏胸膜浸润的患者(HR=2.447, 95% CI 0.336,0.579)和只有PL1浸润的患者(HR=1.287, 95% CI 1.114, 1.487)相比,患者的总生存率较低。胸膜浸润的非小细胞肺癌的治疗包括手术、化疗、放疗和免疫治疗。
Pleural invasion is a recognized adverse prognostic factor in non-small cell lung cancer. Here, we document a case of non-small cell lung cancer in a 66-year-old male presenting with direct invasion of the tumor through lung pleura into the mediastinum. Pleural invasion can proceed past the elastic layer of the visceral pleura, classified as PL1. Less commonly, invasion to the surface of the visceral pleura or parietal pleura can occur and is classified as PL2 and PL3 respectively. PL2 invasion is associated with increased mortality; patients have lower overall survival compared to those without visceral pleural invasion (HR=2.447, 95% CI 0.336,0.579) and those with only PL1 invasion (HR=1.287, 95% CI 1.114, 1.487). Treatment of non-small cell lung cancer with pleural invasion includes surgery, chemotherapy, radiation, and immunotherapy.